順鈉股份(000533.SZ)預計2020年淨利3100萬元-3700萬元 同比增長962%-1167%
格隆匯1月27日丨順鈉股份(000533.SZ)披露2020年度業績預吿,公司預計2020年度實現歸屬於上市公司股東的淨利潤3100萬元-3700萬元,同比增長962%-1167%;公司預計2020年度實現扣除非經常性損益後的淨利潤135萬元-200萬元,而上年同期為虧損3076萬元。
公司預計2020年扣除非經常性損益後的淨利潤扭虧為盈,影響業績變動的主要因素包括:1、公司主營業務收入同比增長,營業利潤預計同比扭虧為盈;2、公司當期非經常性損益約為3200萬元,主要包括政府補助、投資收益、信用減值轉回、預計負債的計提和衝回等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.